LU
Lunai Bioworks Inc.
RENB | US
Overview
Corporate Details
- ISIN(s):
- US29350E1047
- LEI:
- Country:
- United States of America
- Address:
- CENTURY CITY MEDICAL PLAZA, 90067 SUITE 906 LOS ANGELES
- Website:
- https://www.lunaibio.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lunai Bioworks Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Lunai Bioworks Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lunai Bioworks Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops sustainable tech for EV drivetrains and next-gen energy storage materials.
United Kingdom
DGI
United Kingdom
DGI
Developing selective antibody therapies for severe autoimmune diseases.
United States of America
DNTH
United States of America
DNTH
Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.
United States of America
DWTX
United States of America
DWTX
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea
223250
South Korea
223250
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea
383930
South Korea
383930
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan
4576
Japan
4576
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B
Sweden
ECTIN B
Specializing in underwater robotics, AUVs, and sensor systems for marine research and heritage.
Italy
ELB
Italy
ELB
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
United States of America
EDIT
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN
United States of America
ELDN